Evidence map›Paper›PMID 21880431›Full record

ArticleAddictive behaviors2011

Treatment use and barriers among adolescents with prescription opioid use disorders.

Li-Tzy Wu, Dan G Blazer, Ting-Kai Li, George E Woody

Abstract read
In one paragraph

Article in Addictive behaviors, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Prevalence and Health Characteristics of Prescription Opioid Use, Misuse, and Use Disorders Among U.S. Adolescents.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Li-Tzy WuDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham 27710, USA. litzy.wu@duke.edu
Dan G Blazer
Ting-Kai Li
George E Woody
Duke University · USDuke Medical Center · USUniversity of Pennsylvania · US

Funding

Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Delaware Valley Node of the Clinical Trials NetworkU10DA013043 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI WOODY, GEORGE EDWARD · 1999 to 2015
$25.8M
Treatment/Substance Use Disorders/HIV Risk ReductionK05DA017009 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI WOODY, GEORGE EDWARD · 2003 to 2012
$1.3M
MDMA and Other Hallucinogen Use: Onset and Abuse/DependenceR01DA019623 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2013
$1.1M
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN StudiesR33DA027503 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2010 to 2012
$1.1M
Epdemiology of Non-Medical Prescription Anagesic UseR01DA019901 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2009
$416k
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN StudiesR21DA027503 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2009 to 2009
$302k
NIDA NIH HHS HHSN271200522071CNIDA NIH HHS K05 DA017009NIDA NIH HHS K05DA017009NIDA NIH HHS R01 DA019623NIDA NIH HHS R01DA019623NIDA NIH HHS R01 DA019901NIDA NIH HHS R01DA019901NIDA NIH HHS R21 DA027503NIDA NIH HHS R21DA027503NIDA NIH HHS R33 DA027503NIDA NIH HHS R33DA027503NIDA NIH HHS U10 DA013043NIDA NIH HHS U10DA013043NIDA NIH HHS U10 DA013727PHS HHS HSN271200522071C
6 · The paper itself

Abstract

backgroundThis study examined national trends, patterns, correlates, and barriers to substance abuse treatment use by adolescents aged 12-17 years who met at least one of the past-year criteria for prescription opioid abuse or dependence (N=1788).

methodsData were from the 2005-2008 National Surveys of Drug Use and Health (NSDUH). Past-year substance use disorders, major depression, and treatment use were assessed by audio computer-assisted self-interviewing.

resultsAbout 17% of adolescents with opioid dependence (n=434) and 16% of those with opioid abuse (n=355) used any substance abuse treatment in the past year compared with 9% of subthreshold users, i.e., adolescents who reported 1-2 prescription opioid dependence criteria but no abuse criteria (n=999). Only 4.2% of adolescents with opioid dependence, 0.5% of those with abuse, and 0.6% of subthreshold users reported a perceived need for treatment of nonmedical opioid use. Self-help groups and outpatient rehabilitation were the most commonly used sources of treatment. Few black adolescents used treatment (medical settings, 3.3%; self-help groups, 1.7%) or reported a need for treatment (1.8%). Talking to parents/guardians about dangers of substance use increased the odds of treatment use. Barriers to treatment use included "wasn't ready to stop substance use," "didn't want others to find out," and "could handle the problem without treatment."

conclusionsAdolescents with prescription opioid use disorders markedly underutilize treatment. Non-financial barriers are pervasive, including stigma and a lack of perceived treatment need.

Indexed as

Prescription DrugsAdolescentAdolescent BehaviorAmbulatory CareChildCross-Sectional StudiesDepressive DisorderDiagnostic and Statistical Manual of Mental DisordersFemaleHealth Services AccessibilityHealth SurveysHumansMaleOpioid-Related DisordersSelf-Help GroupsUnited StatesPrescription Drugs

Identifiers

PMID21880431
PMCPMC3179790
OpenAlexW2087486254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.